Inovio Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Plymouth Meeting, PA
INO chart
What traders are saying about $INO
Latest postsInovio Pharmaceuticals, Inc. news
- Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch ·
- INOVIO Pharmaceuticals to release third quarter financial results on November 10
Traders Union ·
- Inovio Pharmaceuticals Underwriters Exercise Option for Additional Shares
TipRanks ·
- Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
Investing.com Canada ·
- INO: Inovio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a...
Quantisnow ·
- Inovio Pharmaceuticals Raises $80.5 Million in Public Offering of Shares and Warrants
TradingView ·
- Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history
Yahoo Finance Singapore ·
- Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Inovio Pharmaceuticals Inc (GBM.HA) stock price, news, quote and history
Yahoo Finance UK ·
- Street Calls of The Week
Yahoo Finance ·
- ICYMI: FDA Approves INOVIO’s First DNA Medicine for Rare Disease
MyChesCo ·
- Inovio Pharmaceuticals Inc expected to post a loss of 20 cents a share - Earnings Preview
TradingView ·
Inovio Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $65,343 | $217,756 | $832,010 | $10.3M |
| Net income | -$85.0M | -$107.0M | -$135.0M | -$279.8M |
| Diluted EPS | $-1.81 | $-3.95 | $-6.09 | $-14.07 |
| Total assets (year end) | $74.3M | $113.2M | $171.0M | $348.5M |
| Cash and equivalents (year end) | $44.3M | $65.8M | $14.3M | $46.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Inovio Pharmaceuticals, Inc.
- Ticker
- INO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Plymouth Meeting, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Frequently asked questions
What exchange is Inovio Pharmaceuticals, Inc. listed on?
Inovio Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol INO.
What industry is Inovio Pharmaceuticals, Inc. in?
Inovio Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Inovio Pharmaceuticals, Inc. headquartered?
Inovio Pharmaceuticals, Inc.'s business address on file with the SEC is in Plymouth Meeting, PA.
When does Inovio Pharmaceuticals, Inc.'s fiscal year end?
Inovio Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Inovio Pharmaceuticals, Inc. report?
Inovio Pharmaceuticals, Inc. reported $65,343 in revenue for calendar year 2025, according to its SEC filings.